<DOC>
	<DOCNO>NCT00850161</DOCNO>
	<brief_summary>The purpose study determine glucose peak higher earlier meal patient give intranasal insulin instead conventional insulin treatment .</brief_summary>
	<brief_title>Intranasal Insulin Its Effect Postprandial Metabolism Comparison Subcutaneous Insulin</brief_title>
	<detailed_description>Diabetes mellitus common metabolic disorder characterize hyperglycemia untreated associated microvascular disease . Most people type 1 diabetes treat combination long-acting ( basal ) insulin short-acting ( prandial ) insulin administer prior meal . This necessitate multiple daily injection ( &gt; 3 ) significant barrier long-term compliance treatment . Intranasal administration insulin develop effort overcome need insulin injection prior meal . The pharmacokinetic property confer insulin route administration suggest postprandial glucose disposal may stimulate lead low glucose concentration comparison dose via route . We propose study postprandial glucose turnover healthy volunteer Type 1 diabetes determine effect intranasal insulin glucose disposal . We wish order develop great understand different bioavailability timing intranasal insulin might alter postprandial glucose disposal suppression endogenous glucose production . In order address question address specific aim : - Peak postprandial glucose disposal high occur earlier , presence intranasal insulin administration conventional form insulin dose . - Peak suppression endogenous glucose production great occur early , presence intranasal insulin administration conventional form insulin dose .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Diagnosis Type 1 Diabetes Age 1850 Treatment management MDI ( multiple daily injection ) Insulin Pump BMI 1930 Kg/M2 HbA1c less equal 8.0 % 75 g OGTT ( oral glucose tolerance test ) study insulin concentration &gt; 80uU/mL Active Proliferative Retinopathy Active Nephropathy Chronic Upper Respiratory Conditions determine MD Pregnant Lactating Female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Nasal Insulin</keyword>
	<keyword>Insulin Deficiency</keyword>
	<keyword>Insulin-Dependent</keyword>
</DOC>